Back to top

Image: Bigstock

Should Value Investors Buy GoHealth (GOCO) Stock?

Read MoreHide Full Article

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.

GoHealth (GOCO - Free Report) is a stock many investors are watching right now. GOCO is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A.

We should also highlight that GOCO has a P/B ratio of 0.73. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 1.63. Over the past year, GOCO's P/B has been as high as 0.97 and as low as 0.29, with a median of 0.70.

Value investors also use the P/S ratio. The P/S ratio is is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. GOCO has a P/S ratio of 0.54. This compares to its industry's average P/S of 1.01.

These are only a few of the key metrics included in GoHealth's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, GOCO looks like an impressive value stock at the moment.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


GoHealth, Inc. (GOCO) - free report >>

Published in